Table 1.
Name | Indications | Launch Year in China |
|
---|---|---|---|
Intervention group | Rituximab | Non-Hodgkin’s lymphoma | 2000 |
Trastuzumab | Stomach cancer; Breast cancer | 2002 | |
RHE | Lung cancer | 2005 | |
Comparison group | Pegaspargase | Acute Lymphocytic Leukemia | 2009 |